Read Time:11 Second
The U.S. Food and Drug Administration (FDA) has issued five observations to the biologics manufacturing facility of generic drugmaker Dr. Reddy’s Laboratories in Hyderabad. The observations followed a preapproval inspection (PAI) of the facility in…